2m 2m 2m 2m 2m 2m 2m
BICARA THERAP (BCAX)
NASDAQ
$22.85+$0.04 (+0.15%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.5BMarket Cap
- 96.30%1-Year Change
- BiotechnologyIndustry
BICARA THERAP (BCAX)
$22.85+$0.04 (+0.15%)
BCAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $22.81 | ||
Change | -$0.29 (-1.26%) | ||
Open | $23.29 | ||
High | $24.23 | ||
Low | $22.40 | ||
Previous Close | $23.10 | ||
Volume | 471,459 | ||
30-Day Average Volume | 518,438 | ||
1-Week Change | -1.55% | ||
1-Month Change | -4.00% | ||
1-Year Change | 96.30% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 66.2M | ||
Total Assets | $512.2M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$55.4M | ||
Free Cash Flow | -$44.3M | ||
EBIT | -$55.4M | ||
EBITDA | -$55.3M | ||
Net Working Capital | $460.3M | ||
EPS | -$0.82 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -28 | ||
PEG | -2 | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue